The hydroxyl groups of poly(ethylene glycol), dextran and poly-[N5-(2-hydroxy-ethyl-L-glutamineI were activated using the 4-nitrophenyl chloroformate method. The resulting phenyl carbonate groups reacted quantitatively with the primary amine groups of oligopeptides with 2-(5-fluorouracil-1-yl) glycine ethyl ester moiety as C-terminus. Following this procedure, 5-fluorouracil-polymer conjugates with peptide chains of different amino acid sequences and configurations were synthesized. The conjugates showed a good hydrolytic stability in buffer solutions of pH 7.4 and 5.5, as well as in calf serum, which indicated good stability of the polymer-drug linkage in the blood.
Get full access to this article
View all access options for this article.
References
1.
1. Sezaki, H., Y. Takaura and M. Hashida. 1989. Adv. Drug Deliv. Rev., 3:247.
2.
2. Sinko, P. and J. Kohn. 1993. Polymeric Delivery Systems. Properties and Applications. M. A. El-Nokaly, D. M. Piatt and A. Charpantier, eds., Washington, D.C.: ACS Symposium Series 520, p. 18.
3.
3. Maeda, H. and T. Matsumura. 1989. CRC Crit. Rev. Therap Drug Carrier Syst., 6:193.
4.
4. Seymour, L. W.1992. CRC Crit. Rev. Therapy Drug Carrier Syst., 9:135.
6. Flanagan, P. A., P. Kopeckova, J. Kopecek and R. Duncan. 1989. Biochim. Biophys. Acta, 993:83.
7.
7. Vansteenkiste, S., E. Schacht, R. Duncan, L. Seymour, I. Pawluczyk and R. Baldwin. 1993. J. Controlled Release, 16:91.
8.
8. Gonsho, A., K. Erie, H. Susaki, H. Iwasawa, S. Okuno and T. Sugawara. 1994. Biol. Pharm. Bull., 17:275.
9.
9. Trouet, A., M. Masquelier, R. Baurain and D. Deprez-De Campeneere. 1982. Proc. Natl. Acad. Sci. USA, 79:626.
10.
10. Kopecek, J.1984. Biomaterials, 5:19.
11.
11. Calabresi, P. and R. E. Parks, Jr.1985. Pharmacological Basis of Therapeutics. 7th EdL. S. Goodman, T. W. Raal and F. Murad, eds., New York: McMillan, p. 1268.
12.
12. Chabner, B. A.1982. Pharmacological Principles of Cancer Treatment, B. A. Chabner, ed., Philadelphia, PA: Saunders, p. 132.
13.
13. Balis, F. M., J. S. Holeenberg and W. A. Bleyer. 1983. Clin. Pharmacokinet., 8:202.
14.
14. Akashi, M. and K. Takemoto. 1990. Adv. Polymer Sci., 97:108.
15.
15. Neung, J. L., S. H. Chang and J. Ch. Won. 1992. J. Macromol. Sci., Pure Appl. Chem., A29:161.
16.
16. Kuzuya, M., S. Kondo and A. Noguchi. 1991. Macromolecules, 24:4047.
17.
17. Ouchi, T., H. Yuyama and O. Vogl. 1987. J. Macromol. Chem., Pure Appl. Chem., A24:1011.
18.
18. Ouchi, T., H. Yuyama and O. Vogl. 1987. J. Polymer Sci., Polymer Lett. Ed., 25:279.
19.
19. Ouchi, T., Y. Hagihara, K. Takahashi, Y. Takano and I. Igarashi. 1992. Drug Design Discovery, 9:93.
20.
20. Ouchi, T., A. Fujino, K. Tnaka and T. Banba. 1990. J. Controlled Release, 12:143.
21.
21. Ohya, Y., H. Kobayashi and T. Ouchi. 1991. Reactive Polymers, 15:153.
22.
22. Ouchi, T., H. Kobayashi and T. Banba. 1990. Brit. Polymer J., 23:221.
23.
23. Ouchi, T., T. Banba, M. Fujimoto and S. Hamamoto. 1989. Makromol. Chem., 190:1817.
24.
24. Ouchi, T., T. Banba and T. Matsumoto. 1989. J. Bioact. Comp. Polymers, 4:362.
25.
25. Ohya, Y., K. Inosaka and T. Ouchi. 1992. Chem. Pharm. Bull., 40:59.
26.
26. Ouchi, T., T. Banba, T. Matsumoto, S. Suzuki and M. Suzuki. 1990. Drug Design Delivery, 6:281.
27.
27. Móra, M. and J. Pato. 1990. Makromol. Chem., 191:1051.
28.
28. Chung, S. M., E. J. Yoon and S. M. Kim. 1991. Int. J. Pharm., 68:61.
29.
29. Yang, F. and R. Zhuo. 1990. Polymer J., 22:572.
30.
30. Liao, J. and R. Zhuo. 1993. Polymer J., 25:401.
31.
31. Nichifor, M. and E. Schacht. 1994. Tetrahedron, 50:3747.
32.
32. Bundgaard, H. Adv. Drug Deliu. Rev., 3:39.
33.
33. Amsberry, K. L. and R. T. Borchardt. 1991. Pharm. Res., 8:323.
34.
34. Wolfe, J. L., D. V. Velde and R. T. Borchardt. 1992. J. Org. Chem., 57:6138.
35.
35. Nichifor, M. and E. Schacht. Int. J. Parm., submitted.
36.
36. Bodor, N.1981. Drugs Future, 6:165.
37.
37. Pitman, I. H.1981. Med. Res. Rev., 1:189.
38.
38. De Marre, A., H. Soyez and E. Schacht. 1994. J. Controlled Release, 32:129.
39.
39. Nichifor, M. and E. Schacht. Tetrahedron Lett., submitted.
40.
40. Calicetti, P., C. Monfardini, L. Sartore, O. Schiavon, F. Baccichetti, F. Carlassare and F. M. Veronese. 1993. Il Farmaco, 48:919.
41.
41. Greenwald, R. B., A. Pendri, D. Bolikal and C. W. Gilbert. 1994. Bioorg. Med. Chem. Lett., 4:2465.
42.
42. Hashida, M., A. Kato, Y. Takakura and H. Sezaki. 1984. Drug Metab. Disp., 12:482.
43.
43. Levi-Schaffer, F., A. Bernstein, A. Meshorer and R. Arnon. 1982. Cancer Treat. Rep., 66:107.
44.
44. Hanhauser Riedl, S., E. Hausmann, H. D. Schick, R. Bender, H. Dietzfelbinger, J. Rastetter and A. R. Hanauske. 1993. Invest. New Drugs, 11:185.
45.
45. Büttner, W., M. Becker, Ch. Rupprich, H. F. Boeden, P. Henklein, F. Loth and H. Dauntzenberg. 1989. Biotechn. Bioeng, 33:26.
46.
46. Ramírez, J. C., M. Sánchez-Chaves and F. Arranz. 1993. Angew. Makromol. Chem., 206:77.
47.
47. Lee, W. Y. and A. H. Sehon. 1978. Immunol. Rev., 41:200.
48.
48. Veronese, F. M., R. Largajolli, E. Boccu, C. A. Benassi and O. Schiavon. 1985. Appl. Biochem. Biotechn., 11:141.
49.
49. Tondelli, L., M. Laus, A. Sante Angeli and P. Ferruti. 1985. J. Controlled Release, 1:251.
50.
50. Doane, W. M.1968. Carbohydr. Res., 8:266.
51.
51. Sánchez-Chaves, M. and F. Arranz. 1985. Makromol. Chem., 186:17.
52.
52. Vandoorne, F., R. Vercauteren, D. Permentier and E. Schacht. 1985. Makromol. Chem., 186:2455.
53.
53. Koltsova, G. N., N. K. Krylova, A. E. Vasilev, A. H. Ovsepyan, V. M. Shliman, G. Ya. Rosenberg. 1977. Zh. Obshch. Khim., 47:1177.
54.
54. De Marre, A. and E. Schacht. 1992. Makromol. Chem., 193:3023.
55.
55. Forfier, G. and M. Laliberté. 1993. Biotechn. Appl. Biochem., 17:115.
56.
56. Vansteenkiste, S., A. De Marre and E. Schacht. 1992. J. Bioact. Comp Polymers, 7:4.
